These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 608528)

  • 1. Possible immunological action of Vibrio cholerae neuraminidase (VCN) in tumor immunotherapy.
    Sedlacek HH; Johannsen R; Seiler FR
    Dev Biol Stand; 1977 Apr 13-15; 38():387-98. PubMed ID: 608528
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of Vibrio cholerae neuraminidase on the phagocytosis of E. coli by macrophages in vivo and in vitro.
    Knop J; Ax W; Sedlacek HH; Seiler FR
    Immunology; 1978 Mar; 34(3):555-63. PubMed ID: 346477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Vibrio cholerae neuraminidase on the mitogen response of T lymphocytes. I. Enhancement of macrophage T-lymphocyte cooperation in concanavalin-A-induced lymphocyte activation.
    Knop J
    Immunobiology; 1980 Dec; 157(4-5):474-85. PubMed ID: 6969689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous mammary tumors in mongrel dogs. A relevant model to demonstrate tumor therapeutical success by application of neuraminidase-treated tumor cells.
    Sedlacek HH; Seiler FR
    Dev Biol Stand; 1977 Apr 13-15; 38():399-412. PubMed ID: 608530
    [No Abstract]   [Full Text] [Related]  

  • 5. Stimulatory effect of Vibrio cholerae neuraminidase on the antibody response to various antigens.
    Knop J; Sedlacek HH; Seiler FR
    Immunology; 1978 Feb; 34(2):181-7. PubMed ID: 342397
    [No Abstract]   [Full Text] [Related]  

  • 6. [Transplantability and immunogenicity in mice of lymphoma Nk/Ly cells modified by concanavalin A and neuraminidase].
    Bratus' GG; Darchuk GF
    Eksp Onkol; 1989; 11(3):35-8. PubMed ID: 2752940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuraminidase-induced enhanced immune response can be attributed to immune stimulatory and antigenic properties of the enzyme.
    Johannsen R; Sedlacek HH; Seiler FR
    Transplant Proc; 1979 Jun; 11(2):1411-2. PubMed ID: 473363
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of treatment with neuraminidase on the immunogenicity of ATPC tumor cells].
    Iorio AM; Rivosecchi P; Santoni A; Fabiani L
    Boll Soc Ital Biol Sper; 1973 Mar; 49(9):462-6. PubMed ID: 4787510
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuraminidase immunotherapy of tumors in man.
    Rosato FE; Brown AS; Miller EE; Rosato EF; Mullis WF; Johnson J; Moskovitz A
    Surg Gynecol Obstet; 1974 Nov; 139(5):675-82. PubMed ID: 4428323
    [No Abstract]   [Full Text] [Related]  

  • 10. Specific effect of neuraminidase on blastogenic response of sensitized lymphocytes.
    Han T
    Immunology; 1975 Feb; 28(2):283-6. PubMed ID: 1168168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzymically-modified human mammary carcinoma cells: modulators of macrophage functions.
    Hakim AA
    Cancer Biochem Biophys; 1979; 3(2):85-92. PubMed ID: 121921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of the enzyme neuraminidase for immunotherapeutic treatment of chemically induced carcinogenesis].
    Maĭskiĭ IN; Aĭrapet'ian GP; Kobrinskiĭ GD; Troitskaia NA; Gudkova GB
    Biull Eksp Biol Med; 1977 Dec; 84(12):714-7. PubMed ID: 413595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuraminidase alteration of human lymphocyte reactivity to mitogens, antigens and allogenic lymphocytes.
    Pauly JL; Germain MJ; Han T
    J Med; 1978; 9(3):223-36. PubMed ID: 283169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The morphofunctional characteristics of lymphoma NK/LY cells treated with concanavalin A and Vibrio cholerae neuraminidase].
    Bratus' GG; Naumenko OI; Nastenko EP; Novichenko NL
    Tsitologiia; 1990; 32(1):67-73. PubMed ID: 2375060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of vibrio-cholerae neuraminidase (VCN) on the NK activity of peripheral blood lymphocytes in patients with cancer].
    Ohida J
    Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):114-21. PubMed ID: 3379327
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhancement of delayed skin hypersensitivity by neuraminidase in cancer patients.
    Han T
    Clin Exp Immunol; 1974 Sep; 18(1):95-100. PubMed ID: 4469229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy with neuraminidase-treated tumor cells after radiotherapy.
    Song CW; Levitt SH
    Radiat Res; 1975 Dec; 64(3):485-91. PubMed ID: 1197655
    [No Abstract]   [Full Text] [Related]  

  • 18. [Action of Vibrio cholera neuraminidase on chemically induced carcinogenesis].
    Solov'ev VD; Maĭskiĭ IN; Aĭrapet'ian GP; Kobrinskiĭ GD; Gudkova RB
    Vestn Akad Med Nauk SSSR; 1974; (8):63-6. PubMed ID: 4471645
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experiments on the treatment of Yoshida tumor with neuroaminidase of Vibrio cholerae].
    Sánchez Cousteau JA; Justo Alpañes E; Ledro Molina D; Ferreiro Madueño M; Gomez Parra M; Ramírez Martínez R; Valle Bernal MJ; Astolfi Pérez de Guzmán J; Garrido Peralta M
    Rev Clin Esp; 1979 Sep; 154(5):183-6. PubMed ID: 523718
    [No Abstract]   [Full Text] [Related]  

  • 20. Antitumor immune response following injection of neuraminidase-treated sarcoma cells.
    Faraci RP; Marrone JA; Ketcham AS
    Ann Surg; 1975 Mar; 181(3):359-62. PubMed ID: 1130852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.